(BSNS WIRE) Effect of Magnetic Resonance on Pain to be Quantified at the
Effect of Magnetic Resonance on Pain to be Quantified at the University of
Oklahoma
Business Editors/Health & Medical Writers
BOCA RATON, Fla.--(BUSINESS WIRE)--April 8, 1999--Jacobson
Resonance Enterprises Inc. (OTC BB:JRSE) announced Thursday that the
company has entered into a research agreement with the Board of
Regents of the University of Oklahoma.
The project title is "Responses of Thoracic Spinal Neurons to
Activation of Cardiac Nociceptors (pain transmitters) while using
Magnetic Resonance," and magnetic resonance will be accomplished with
a Jacobson Resonator.
Anecdotal reports suggest that magnetic fields provide different
levels of pain relief in a variety of pain patients. Well documented
studies to quantitate the effectiveness of electromagnetic fields do
not exist in the literature. Thus, the purpose of this study is to
quantitate the activity recorded from cells in the spinal cord that
respond to pain stimulation from the heart. Anesthetized male rats will
be used as the animal model. The principal investigator, Professor
Robert Foreman, Chairman of Physiology, has stated: "The hypothesis of
this study is that cell activity in the thoracic spinal cord decreases
when Jacobson magnetic fields are directed to the heart during
activation of cardiac nociceptors (pain transmitters). To address the
hypothesis, we will determine the effects of electromagnetic field
stimulation on extracellular action potentials of spinal neurons
located in the gray matter of the T1 - T5 spinal cord segments."
The protocol for magnetic stimulation will be specified by Dr.
Jerry Jacobson, chairman and CEO of Jacobson Resonance Enterprises,
and further optimized with the expertise of Professor William
Yamanashi of the University of Oklahoma V.A. Medical Center. Doctors
Jacobson and Yamanashi have worked together for many years publishing
in scientific periodicals their theoretical vision explaining the
initial physical mechanism for bioeffects secondary to extremely weak,
low frequency, electromagnetic field exposures. Dr. Foreman concluded
the proposal for the study by saying, "We believe this quantitative
analysis will provide important insights about effects of
electromagnetic field stimulation on pain and in particular angina
pectoris."
Jacobson Resonance Enterprises Inc. is establishing itself as a
leader in the emerging field of bio-electromagnetic resonance. The
company's proprietary technology known as Jacobson Resonance has
applications that cut across the medical, pharmaceutical, food and
beverage, construction and environmental industries.
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. The
matters covered by such forward-looking statements are subject to
known and unknown risks, uncertainties and other factors which may
cause actual results, performance or achievements of the company to
differ materially from those contemplated or implied by such
forward-looking statements.
--30--jd/mi*
CONTACT: Jacobson Resonance Enterprises Inc., Juno Beach, Fla.
Investor Relations:
Debra Jacobson, 561/626-8483
561/748-8870 FAX
Website: www.JRSE.com
KEYWORD: FLORIDA
INDUSTRY KEYWORD: MEDICINE PHARMACEUTICAL FOODS/BEVERAGES
EDUCATION BUILDING/CONSTRUCTION
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
*** end of story *** |
